These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 8905828

  • 21. Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.
    Schou M, Pike VW, Sóvágó J, Gulyás B, Gallagher PT, Dobson DR, Walter MW, Rudyk H, Farde L, Halldin C.
    Bioorg Med Chem; 2007 Jan 15; 15(2):616-25. PubMed ID: 17123820
    [Abstract] [Full Text] [Related]

  • 22. [11C]WAY 100635: a radioligand for imaging 5-HT1A receptors with positron emission tomography.
    Mathis CA, Simpson NR, Mahmood K, Kinahan PE, Mintun MA.
    Life Sci; 1994 Jan 15; 55(20):PL403-7. PubMed ID: 7968222
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
    Jarkas N, McConathy J, Votaw JR, Voll RJ, Malveaux E, Camp VM, Williams L, Goodman RR, Kilts CD, Goodman MM.
    Nucl Med Biol; 2005 Jan 15; 32(1):75-86. PubMed ID: 15691664
    [Abstract] [Full Text] [Related]

  • 24. Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique.
    Ito H, Halldin C, Farde L.
    J Nucl Med; 1999 Jan 15; 40(1):102-9. PubMed ID: 9935065
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of [O-methyl-11C]RS-15385-197 as a positron emission tomography radioligand for central alpha2-adrenoceptors.
    Hume SP, Hirani E, Opacka-Juffry J, Osman S, Myers R, Gunn RN, McCarron JA, Clark RD, Melichar J, Nutt DJ, Pike VW.
    Eur J Nucl Med; 2000 May 15; 27(5):475-84. PubMed ID: 10853800
    [Abstract] [Full Text] [Related]

  • 26. [O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations.
    Lundkvist C, Halldin C, Swahn CG, Hall H, Karlsson P, Nakashima Y, Wang S, Milius RA, Neumeyer JL, Farde L.
    Nucl Med Biol; 1995 Oct 15; 22(7):905-13. PubMed ID: 8547888
    [Abstract] [Full Text] [Related]

  • 27. Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomography.
    Langer O, Halldin C, Chou Y, Sandell J, Swahn C, Någren K, Perrone R, Berardi F, Leopoldo M, Farde L.
    Nucl Med Biol; 2000 Nov 15; 27(8):707-14. PubMed ID: 11150701
    [Abstract] [Full Text] [Related]

  • 28. First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635.
    Pike VW, McCarron JA, Lammerstma AA, Hume SP, Poole K, Grasby PM, Malizia A, Cliffe IA, Fletcher A, Bench CJ.
    Eur J Pharmacol; 1995 Sep 05; 283(1-3):R1-3. PubMed ID: 7498295
    [Abstract] [Full Text] [Related]

  • 29. P-[18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans.
    Shiue CY, Shiue GG, Mozley PD, Kung MP, Zhuang ZP, Kim HJ, Kung HF.
    Synapse; 1997 Feb 05; 25(2):147-54. PubMed ID: 9021895
    [Abstract] [Full Text] [Related]

  • 30. Different brain radioactivity curves in a PET study with [11C]beta-CIT labelled in two different positions.
    Lundkvist C, Halldin C, Swahn CG, Ginovart N, Farde L.
    Nucl Med Biol; 1999 May 05; 26(4):343-50. PubMed ID: 10382835
    [Abstract] [Full Text] [Related]

  • 31. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse.
    Laporte AM, Lima L, Gozlan H, Hamon M.
    Eur J Pharmacol; 1994 Dec 27; 271(2-3):505-14. PubMed ID: 7705451
    [Abstract] [Full Text] [Related]

  • 32. Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.
    Andrée B, Halldin C, Thorberg SO, Sandell J, Farde L.
    Nucl Med Biol; 2000 Jul 27; 27(5):515-21. PubMed ID: 10962260
    [Abstract] [Full Text] [Related]

  • 33. Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET.
    Pike VW, Halldin C, Nobuhara K, Hiltunen J, Mulligan RS, Swahn CG, Karlsson P, Olsson H, Hume SP, Hirani E, Whalley J, Pilowsky LS, Larsson S, Schnell PO, Ell PJ, Farde L.
    Eur J Nucl Med Mol Imaging; 2003 Nov 27; 30(11):1520-8. PubMed ID: 14579092
    [Abstract] [Full Text] [Related]

  • 34. Derivatives of WAY 100635 as potential imaging agents for 5-HT1A receptors: syntheses, radiosyntheses, and in vitro and in vivo evaluation.
    Wilson AA, Inaba T, Fischer N, Dixon LM, Nobrega J, DaSilva JN, Houle S.
    Nucl Med Biol; 1998 Nov 27; 25(8):769-76. PubMed ID: 9863565
    [Abstract] [Full Text] [Related]

  • 35. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET.
    Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW, Hume SP, Grasby PM, Lammertsma AA.
    Neuroimage; 1998 Nov 27; 8(4):426-40. PubMed ID: 9811559
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Optimal metabolite curve fitting for kinetic modeling of 11C-WAY-100635.
    Wu S, Ogden RT, Mann JJ, Parsey RV.
    J Nucl Med; 2007 Jun 27; 48(6):926-31. PubMed ID: 17504866
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Quantification of serotonin 5-HT1A receptors in humans with [11C](R)-(-)-RWAY: radiometabolite(s) likely confound brain measurements.
    Zhang XY, Yasuno F, Zoghbi SS, Liow JS, Hong J, McCarron JA, Pike VW, Innis RB.
    Synapse; 2007 Jul 27; 61(7):469-77. PubMed ID: 17415792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.